The aim of this study was to investigate the effects of dietary conjugated linoleic acid (CLA) and phytosterol supplementation and their combination on antioxidant enzyme activities and biomarkers of lipid peroxidation in healthy rats. Forty male Sprague-Dawley rats were divided into five groups and received diets supplemented with 2% of soybean oil (group S), safflower oil (group LA) (control), a mixture of c9,t11 and t10,c12 CLA (group CLA), phytosterols (group P) and a mixture of CLA and phytosterols (group CLA + P) for 9 weeks. Plasma and hepatic indicators of lipid autoxidation and plasma antioxidant enzymes activities were determined. The supplementation with the mixture of CLA and phytosterols (CLA + P) did not alter food intake, weight gain, plasma malondialdehyde (MDA) and glutathione (GSH) values, superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione reductase (GRd) activities (P > 0.05). The supplementation with CLA significantly increased plasma catalase (CAT) activity (3.7-fold) and plasma 8-isoprostane values (60%) compared to S group (P b 0.05). However, the association between CLA and phytosterols was able to restore the CAT and 8-isoprostane levels to basal values, since these indicators in the CLA + P group were statistically similar to S group. CLA + P supplementation also decreased lipid peroxidation primary (58%) and secondary (52%) products in liver (Pb 0.05). Supplementation of isolated phytosterols and CLA was also able to reduce hepatic lipid peroxidation products and plasma levels of MDA (P b 0.05). The dietary combination of CLA +P improved the antioxidant status, reduced the lipid peroxidation and protected against possible effects of CLA supplementation on oxidative stress in vivo.
Introduction
Conjugated linoleic acid (CLA) represents a group of positional and geometric isomers with conjugated double bonds of the octadecadienoic acid (18:2n− 6) and is naturally produced in animals by the process of bacterial biohydrogenation of linoleic acid in rumen (Pariza, Park, & Cook, 2001) . They are found in small amounts in a large variety of foods, like in meats and dairy products and the most abundant isomer is the cis-9, trans-11-CLA (c9,t11) (Chin, Liu, Storkson, Ha, & Pariza, 1992; Kepler, Hirons, McNeill, & Tove, 1966) . Commercial preparations of CLA are made of linoleic acid from safflower or sunflower oils under alkaline conditions and are usually a 1:1 mixture of c9,t11 and trans-10, cis-12 (t10,c12) CLA with other isomers in minor concentrations (Pariza et al., 2001) .
Several studies have shown the biological effects of CLA isomers, including anticarcinogenic properties, body composition change, prevention of atherosclerosis, enhancement of bone mineralization, immune system modulation and improvement of insulin resistance (Bhattacharya, Banu, Rahman, Causey, & Fernandes, 2006; Park, 2009) . It has been also reported that CLA protects against oxidative stress and lipid peroxidation in animal models (Cantwell, Devery, O'shea, & Stanton, 1999; Ip, Chin, Scimeca, & Pariza, 1991; Kim et al., 2005; Moon et al., 2009 ). On the other hand, adverse effects of CLA supplementation have also been studied, particularly regarding increased susceptibility to lipid autoxidation (Basu, Risérus, Turpeinen, & Vessby, 2000; Basu, Smedman, & Vessby, 2000; Risérus, Vessby, Ärnlöv, & Basu, 2004; Yamasaki et al., 2000) . However, metabolic effects of CLA in animals are divergent, not completely elucidated, and further investigations are needed, particularly concerning biological lipid oxidation.
Phytosterols (plant sterols) are bioactive components of all vegetable foods. In plants, more than 200 different types of phytosterols have been reported and the principal plant sterols are β-sitosterol (24-α-ethylcholesterol), campesterol (24-α-methylcholesterol) and stigmasterol (Δ 22 , 24-α-ethylcholesterol) (Moreau, Whitaker, & Hicks, 2002) . They have been shown to be effective, and no adverse effects have been observed when added to foodstuffs, furthermore, they are listed as GRAS (Generally Recognized as Safe) by the Food and Drug Administration for the general population (Hicks & Moreau, 2001; Kritchevsky & Chen, 2005) . They have been used as blood cholesterol-lowering agents for the last half century and the effect of these compounds on plasma lipid levels has been tested in animals and humans (Jong, Plat, & Mensink, 2003; Moghadasian & Frohlich, 1999) . Although most studies have focused on the hypocholesterolemic activity of phytosterols, other biological properties such as antioxidant activity have also been attributed to these plant compounds in foods, animal models and human studies (Fuhrman, Plat, Herzog, & Aviram, 2007; Mannarino et al., 2009; Summanen et al., 2003; Wang, Hicks, & Moreau, 2002) .
It has been postulated that a network of antioxidants with different chemical properties may work in a synergistic way, protecting cells and tissues from damage (Jacobs & Steffen, 2003) . Recently, it was shown that the combination of CLA and natural compounds from marine plant extracts could exert beneficial effects related to lipid metabolism in obese rats (Hu et al., 2012) .
In view of a possible pro-oxidant action of CLA (as it is a conjugated diene), its supplementation in association with the antioxidant protection could minimize the deleterious action of CLA on the process of biological lipid oxidation. Thus, the aim of the present study was to investigate the effect of CLA and phytosterol supplementation, alone or in combination, on the process of lipid autoxidation and in antioxidant enzyme activities in healthy Sprague-Dawley rats.
Materials and methods

Supplements
Safflower oil, CLA Tonalin® and phytosterol Vegapure® 95FF were supplied by Cognis Brasil Ltda.
Determination of fatty acid profiles of lipid supplements
The fatty acid compositions of the different lipid supplements (soybean oil, safflower oil, CLA and phytosterols) were determined by gas chromatography (GC) (Kramer et al., 1997 ) using a capillary GC Agilent 6850 Series GC System, capillary column DB-23 Agilent (50% cyanopropyl-methylpolysiloxane, 60 m x 0.25 mm × 0.25 μm); helium was used as carrier gas. Sample methylation and esterification were performed as described by Maia and Rodriguez-Amaya (1993) . Fatty acid methyl esters of the samples were identified by the comparison of their relative retention times with those of commercial standard esters under the same conditions. The fatty acid profile of lipid supplements is presented in Table 1 . The percentages of each lipid compound of interest were used to calculate the exact amount used on the diets.
Phytosterols analysis
The identification and quantification of phytosterols in lipid supplements (soybean oil, safflower oil, CLA and phytosterols) were performed by GC (Becker, Gonçalves, Grimaldi, & Fernandes, 2005) using a GC Agilent 6850 Series GC System equipped with automatic injector, FID detector, software Agillent Chemstation Plus, version A.08xx and a fused silica capillary column LM 5 (5% fenil 95% metilpolisiloxane, 30 m × 0.25 mm× 0.3 μm). The phytosterol profile of lipid supplements is presented in Table 2 . The percentage of total phytosterol was used to calculate the exact amount used on the diets.
Animals and diets
This work was approved by the Ethics Commission on Animal Use (CEUA-IB/UNICAMP, Protocol no. 2296-1) and followed the University guidelines for the use of animals in experimental studies. Forty healthy male Sprague-Dawley rats aged from 21 to 23 days were obtained from the Multidisciplinary Center for Biological Investigation, University of Campinas. AIN-93G diet was prepared monthly according to the American Institute of Nutrition (Reeves, Nielsen, & Fahey, 1993) , with a protein concentration of 12% (Goena et al., 1989) . The soybean oil is the recommended source of fat in the AIN-93 diets, so it was used as a standard source of lipids. The chemically synthesized CLA from a Data are expressed as relative percentages of total methyl esters. b CLA: conjugated linoleic acid. The CLA was 80% pure, and it contained 50% c9,t11
and 50% t10,c12. safflower oil was added to the diets, which is rich in linoleic acid (76.62%), so the safflower oil was used as a control fatty acid, which is in accordance with Yamasaki et al. (2000) . Diet was packed in dark polyethylene bags and stored at −20°C to minimize the oxidation of fatty acids. Animals remained in individual cages for 9 weeks, including an adaptation period of 7 days, with free access to water and feed and maintained in a temperature controlled room (22 ±1°C, 60-70% humidity), using 12 h light/dark cycle. Animals were randomly divided in five experimental groups (n= 8/group) that received diet supplemented with 2% of the compound of interest in each lipid supplement: group S received diet supplemented with soybean oil (as a standard source of lipids); group LA received diet supplemented with safflower oil (as a control fatty acid); group CLA received diet supplemented with CLA Tonalin®; group P received diet supplemented with phytosterol Vegapure® 95FF; and group CLA+ P received diet supplemented with a mixture of CLA and phytosterols. The weight gain was monitored weekly and the food intake was monitored every 2 days during the experimental period. The diets' compositions are presented in Table 3 .
Blood and tissue collection for biochemical analysis
The animals were sacrificed by decapitation preceded by 12-hourfasting after 9 weeks of the experimental period. Blood samples were collected in polyethylene tubes with anticoagulant EDTA to obtain plasma. Tubes were centrifuged at 4°C (3000 rpm for 15 min). After that, supernatant plasma was separated, and stored in polypropylene microtubes at −80°C until analysis. Liver was removed, weighed, frozen in liquid nitrogen and after that stored at −80°C for subsequent analysis.
Plasma antioxidant enzymes activities and biomarkers of lipid peroxidation
Commercial kits from Cayman Chemical (Ann Arbor, MI, USA) were used to determine plasma levels of malondialdehyde (MDA, 10009055), glutathione (GSH, 703002), catalase (CAT, 707002), superoxide dismutase (SOD, 706002), glutathione peroxidase (GPx, 703102) and glutathione reductase (GRd, 703202). 8-Isoprostane (516351) was determined by an enzyme immunoassay kit from Cayman Chemical (Ann Arbor, MI, USA).
Hepatic lipid autoxidation products and total lipid analysis
After euthanasia, liver was lyophilized, milled, and stored at −80°C for subsequent analysis. For the determination of the hepatic peroxide index (primary lipid autoxidation product), lipids were previously extracted from lyophilized liver samples of each animal by the method of the Bligh and Dyer (1959) extraction with some modifications due to sample peculiarities. After lipid extraction, peroxide index determination was performed according to the Association of Official Analytical Chemists (AOAC, 2000) . For the determination of the peroxide index, the amount of lipids present in the chloroform solution resulting from the lipid extraction procedure of Bligh and Dyer (1959) extraction was used. For the determination of the hepatic thiobarbituric acid reactive substances (TBARS -secondary lipid autoxidation product), the method proposed by Sinnhuber and Yu (1958) was used. The method is based in the formation of a pink-red pigment composed of 2 molecules of thiobarbituric acid and 1 of MDA. Results are expressed as mg MDA/kg liver weight.
Statistical analysis
Data are expressed as mean values ±S.E.M. Differences among the groups (S, LA, CLA, P and CLA + P) were tested by one-way analysis of variance (ANOVA) followed by Tukey's test using Statistical Analysis System 9.1.3 software (SAS, 2003) . P ≤0.05 was considered statistically significant.
Results
Animals looked healthy during the study and tolerated well the supplemented diets. Cumulative feed intake was statistically (P b 0.05) lower in CLA group compared to P group, but cumulative body weight gain was similar in all groups (P > 0.05) ( Table 4) .
The CLA supplementation significantly increased 3.7 times plasma CAT activity (Fig. 1.A) and 60% plasma 8-isoprostane values (Fig. 1.B ) compared to S group (P b 0.05). In addition, the association between CLA and phytosterols was able to restore the CAT and 8-isoprostane levels to basal values, since these indicators in the CLA + P group were statistically similar to S group.
There was no significant difference among the experimental groups for plasma GSH level, GRd and GPx activities (P > 0.05) (Fig. 1.C, D, E ).
CLA and P groups showed the lowest (15.16 ± 1.23 U/mL) and the highest (23.38 ± 2.33 U/mL) plasma SOD activity, respectively (P b 0.05). CLA + P group showed SOD values similar to S group ( Fig. 1.F) .
LA, CLA and P groups showed a significant reduction on plasma MDA levels (48%) (P b 0.05) compared to S group (Fig. 1.G) .
The supplementation with CLA (CLA group), phytosterols (P group) and their mixture (CLA+ P group) showed a significant (P b 0.05) reduction on hepatic MDA levels (52%), compared to S and LA groups (Fig. 2.A) . Furthermore, CLA and P groups showed a significant (P b 0.05) reduction on hepatic peroxide index, 25% and 48% compared to S group, respectively, but the combination of the supplements (CLA+ P group) was more efficient and reduced peroxide index levels about 58% compared to S group (Fig. 2.B) . Table 4 Cumulative body weight gain and cumulative food intake in rats fed S, LA, CLA, P and CLA + P diets A . Means followed by different letters in the same line indicate statistical differences by one-way analysis of variance followed by Tukey's test (P≤0.05). Reeves et al. (1993) . S: diet supplemented with soybean oil, LA: diet supplemented with safflower oil, CLA: diet supplemented with conjugated linoleic acid (CLA), P: diet supplemented with phytosterols and CLA + P: diet supplemented with conjugated linoleic acid and phytosterols.
Variables
Discussion
An imbalance in oxygen levels causes the generation of reactive oxygen species (ROS), which promote oxidative stress by damaging macromolecules, contributing to the pathologies of Alzheimer's disease, Parkinson's disease and atherosclerosis (Kulkarni, Kuppusamy, & Parinandi, 2007) . A depletion of antioxidant defenses can also tip the ROS antioxidant balance and cause oxidative stress (Sies, 1991) . Antioxidant based products (drug formulations or plant extracts) are used for the prevention and treatment of complex diseases like diabetes, cardiovascular and neurodegenerative diseases and cancer (Noonan, Benelli, & Albini, 2007) .
Our data show that the animals supplemented with CLA isomers mixture (c9,t11 and t10,c12) showed an increase in plasma 8-isoprostane levels, suggesting that CLA could act as pro-oxidant agent. The 8-isoprostane is a specific product of lipid peroxidation formed in vivo via a non-enzymatic mechanism involving the free radical-catalyzed peroxidation of arachidonic acid (AA) and is the most specific biological indicator for the assessment of oxidative stress in vivo (Musiek, Yin, Milne, & Morrow, 2005) . Values with different letters indicate significant difference by one-way analysis of variance followed by Tukey's test (P ≤ 0.05).
Peroxisomal β-oxidation is regulated by peroxisome proliferator activated receptors (PPAR), like PPARα. Therefore any change in its activity may influence 8-isoprotane concentration. CLA is preferentially β-oxidized in peroxisomes and also avid ligand of PPARα, as shown by Moya-Camarena, Heuvel, Blanchard, Leesnitzer, and Belury (1999) , which may compete with 8-isoprostane, leading to a decrease in their products formation, and might explain the increase of 8-isoprostane during CLA supplementation (Iannone et al., 2009) .
Many studies aimed to assess the oxidative stress by determination of 8-isoprostane in different experimental models, including humans. Basu, Smedman, and Vessby (2000) studied the CLA supplementation in healthy humans for 12 weeks. They found urinary and plasma 8-isoprostane values significantly higher than the control group, and categorically stated that CLA induces lipid peroxidation in humans. Basu, Risérus, Turpeinen, and Vessby (2000) also demonstrated that CLA supplementation for only one month was enough to induce a significant elevation in 8-isoprostane and prostaglandin metabolite levels in the urine in obese patients. Furthermore, their results indicated that CLA probably has a more direct effect on the non-enzymatic than on the enzymatic conversion of AA. Risérus et al. (2004) supplemented obese men for a period of 12 weeks with 3 g/day of CLA mixture containing predominantly the c9,t11 isomer. Urine concentration of 8-isoprostane was 50% higher after supplementation with the CLA isomer than the placebo, indicating that lipid oxidation is increased not only by t10,c12, but by c9,t11 isomer as well.
However, in the present work, the animals supplemented with CLA+ P showed similar plasma 8-isoprostane levels compared to S group. Thus, this suggests that phytosterols could counteract this pro-oxidative effect caused by CLA consumption. Mannarino et al. (2009) found that 6 weeks of phytosterol consumption was associated with a significant plasma 8-isoprostane reduction in humans, suggesting possible antioxidative properties of phytosterols. These results are consistent with our findings, since supplementation of phytosterols prevents the increase of plasma 8-isoprostane levels found in rats fed with CLA, and confirm the beneficial effect of phytosterols in reducing this non-enzymatic product of lipid oxidation in vivo. However, the potential effect of daily phytosterols consumption on this biomarker is still recent and not enough studied.
CAT and SOD are the two most important radical scavenging enzymes and body's secondary defense against oxygen metabolites produced due to transitional heavy metals (Nordenson & Beckman, 1981) . In our data we found that a supplementation of CLA increased the plasma CAT activity. It is known that CLA acts as a PPARα ligand (Moya-Camarena et al., 1999) , and the increase of PPARα expression would cause higher mitochondrial and peroxisome oxidation of fatty acids, and consequently an elevation in H 2 O 2 production, leading to increased CAT activity, which is observed with CLA supplementation in this data.
However, the supplementation with CLA+ P decreased the CAT activity to basal levels when compared to S group, indicating that phytosterols could be responsible for this effect. Some authors suggested that β-sitosterol can protect against oxidative stress through modulation of antioxidant enzymes and free radical production (Moreno, 2003; Vivancos & Moreno, 2005) , which is consistent with our findings. Previous studies have reported that a lower CAT activity would indicate smaller peroxide production, which, in turn, would indicate a lower degree of oxidative stress (Cantwell et al., 1999; Santos-Zago, Botelho, & de Oliveira, 2007) .
We did not observe any difference in GSH levels, GRd and GPx activities among the experimental groups, although few studies have evaluated the effect of CLA in these parameters, with contradictory findings (Moon et al., 2009) .
Lipid peroxidation is a basic cellular deteriorating process induced by oxidative stress and occurs readily in the tissues rich in highly oxidizable polyunsaturated fatty acids, which may lead to cell death and disease in living organisms (Halliwell, 1994) . During the process of lipid peroxidation, hydroperoxide is produced as the first stable product in both the radical and non-radical reactions, and TBARS are the secondary products, which are expressed as MDA, an indicator of cell oxidative stress (Yamasaki et al., 2000) .
With regard to effects of CLA and phytosterols on lipid peroxidation, we found a significant reduction in hepatic peroxide index and in plasma and liver MDA levels, suggesting that CLA and phytosterols could act as antioxidant agents, which is in agreement with several studies about CLA (Ip et al., 1991; Kim et al., 2005; Moon et al., 2009; Santos-Zago et al., 2007) and phytosterol supplementation in animal models (Fuhrman et al., 2007; Summanen et al., 2003) .
Furthermore, the association between CLA and phytosterol supplementation significantly reduced hepatic lipid peroxidation products more than base levels, indicating that this combination potentiated this effect in vivo, which is consistent with previous studies that showed that plant sterols directly affect the lipid peroxidation levels and induce a significant reduction of these products in vitro (Mora-Ranjeva, Charveron, Fabre, Milon, & Muller, 2006; Moreno, 2003; Vivancos & Moreno, 2005) and in vivo (Fuhrman et al., 2007; Summanen et al., 2003) . Another possible key mechanism of the protective effect exerted by phytosterols may involve the strengthening of the intracellular antioxidant defense, which is consistent with the decrease observed in O 2 − and H 2 O 2 levels after β-sitosterol treatment (Moreno, 2003) .
Our results indicate an apparently contradictory effect by the CLA administration related to the increase of plasma 8-isoprostane and decrease of plasma and hepatic MDA values. These results corroborate previously described studies of 8-isoprostane and TBARS or MDA measurements in lipid peroxidation studies (Basu, 1999; Basu, Smedman, & Vessby, 2000; Santos-Zago et al., 2007) . This is possibly because these two biomarkers reflect different stages of lipid peroxidation and/or insufficient sensitivity to detect lipid peroxidation products by measuring MDA in some experimental models, since the TBARS reaction is not specific to MDA (Basu, Smedman, & Vessby, 2000; Morrow & Roberts, 1997) . Other comparative in vivo studies did not show any correlation between the increase in isoprostanes and MDA levels (Basu, 1999 (Basu, , 2007 . Protein oxidation and lipid peroxidation are usually interdependent of each other in biological systems and some studies have shown a correlation between protein oxidation and that of 8-isoprostane, mainly owing to the different character of these oxidative processes (Basu, 2007) . It has been known that lipid peroxidation-derived reactive aldehydes, such as MDA, lipid hydroperoxides and free radicals, contribute to proteins oxidation (Popovic´, Štajner, Slavko, & Bijelic´, 2012) .
Furthermore, according to the reports from Kang and Choi (2008) CLA affects the fatty acid composition in a tissue-specific manner, indicating that the metabolic rate may be slower in the liver than in the plasma, where the plasma may respond more readily to metabolizing the fatty acids, particularly to AA conversion.
These conflicting results related to lipid peroxidation indicators, lead to the discussion that CLA supplementation influenced the process of biological lipid oxidation in different ways, and this influence is dependent on the autoxidation indicator used, including its tissue and determination method. However, a mechanism that can account for these findings cannot be readily outlined.
It is clear that the effects of CLA on oxidative stress are controversial and not completely elucidated. There is no consensus about the real effect of this supplement on the oxidation process of biological lipids, since many studies show antioxidant properties and other possible pro-oxidant effects of CLA, which corroborate our findings.
Another possible explanation for our contradictory results may be related to the fact that the rats were not exposed to oxidative stress. Thus, the methodology used in this study should be applied in a future biological testing in animals exposed to a pro-oxidative agent, and from this, protection of CLA and phytosterols against this agent would be assessed for a longer period.
Thus, with regard to the effects of combination between CLA and phytosterol supplementation, it could be suggested that phytosterols could also act as antioxidant in vivo system, protecting against possible oxidative effects of CLA supplementation, as suggested by our results.
Conclusion
In summary the dietary combination of CLA and phytosterols caused improvement in antioxidant status, reduction in lipid peroxidation and protects against possible effects of CLA supplementation on oxidative stress in rats. However, metabolic effects of this association are divergent and not completely elucidated, so further investigations are needed to clarify the profound synergistic relationship between CLA and phytosterols.
